Company News

DNA Electronics Acquires NanoMR

dnaDNA Electronics (DNAe), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for blood infections, has completed the acquisition of the entire issued share capital of nanoMR, an Albuquerque based developer of a novel system for rapid isolation of rare cells in the bloodstream for a total cash consideration of approximately US$ 24 million by way of a merger under the laws of Delaware, USA.
Integration of the two organisations is effective immediately, creating an 80+ strong team with facilities in the UK and the USA that will operate under the DNAe brand.
The acquisition is a key strategic milestone for DNAe, enabling the Company to integrate nanoMR’s unique immunomagnetic Pathogen Capture System (PCS) with its own Genalysis PCR and semiconductor-based DNA sequencing technology to create a complete blood-to-result solution.
The PCS can target multiple rare cell types such as those contained in bacteria and fungi from bloodstream infections at levels of 1 cell/mL or lower in less than 30 minutes, making it the ideal sample preparation technology for DNAe’s rapid point-of-need diagnostic tests.
DNAe’s proven semiconductor DNA sequencing technology is already licensed to Thermo Fisher and is the core of the Ion TorrentNext Generation Sequencing (NGS) systems as well as to Geneu, a company selling the world’s first in-store DNA test for personalised skincare.
DNAe is developing an integrated instrument and consumable cartridge that will deliver results directly from blood in 2-3 hours. Its first diagnostic product, a test for the rapid diagnosis of bloodstream infections, will identify pathogens in the blood as well as antimicrobial resistance genes. This will allow clinicians to treat patients with appropriate medication before the onset of sepsis, saving lives and reducing the time spent in hospital.
Professor Chris Toumazou, Chairman and CEO of DNAe said: “The acquisition of the nanoMR technology and team underscores our commitment to developing a complete point-of-need solution for diagnosis of infectious diseases, particularly those that cause sepsis, where speed and DNA-specific information can make the difference between life and death. nanoMR brings a game-changing technology, a wealth of scientific expertise and the potential for exciting new applications to DNAe.”

4 Comments

4 Comments

  1. zgrzewarka do rur olx

    January 16, 2018 at 6:15 pm

    I do trust all the ideas you’ve presented for your post. They are very convincing and will certainly work. Nonetheless, the posts are very brief for beginners. May just you please extend them a bit from subsequent time? Thank you for the post.

  2. artykuly bhp

    January 16, 2018 at 11:23 pm

    As soon as I detected this web site I went on reddit to share some of the love with them.

  3. Home Improvement

    January 17, 2018 at 7:33 am

    It is really a great and helpful piece of info. I’m satisfied that you simply shared this helpful information with us. Please stay us informed like this. Thank you for sharing.

  4. Buty Jeansowe Meskie

    January 17, 2018 at 9:08 am

    Some truly quality blog posts on this web site , saved to favorites .

Leave a Reply

Your email address will not be published.

Most Popular

 

About Us

eHEALTH, as an online and print platform, elegantly guides the healthcare stakeholders through the trajectory of healthcare that witnesses fascinating changes on a daily basis due to increased technological intervention and other structural changes to create a ‘community of practice’ of healthcare stakeholders.

email: info@elets.in

Contact Us

Elets Technomedia Pvt. Ltd.
Stellar IT Park, Office No. 7A/7B, 5th Floor, Tower -2 Annexe Building, C-25, Sector 62 Noida, Uttar Pradesh - 201309, India

Copyright © 2018 Elets | All rights reserved

To Top